# Clinical Trial Analysis - Squamous Cell Carcinoma (SCC) Tumors

## Background

This analysis focuses on a clinical trial involving **249 mice** with squamous cell carcinoma (SCC) tumors, treated with various drug regimens over **45 days**. The primary goal is to evaluate the performance of **Capomulin**, Pymaceuticals' drug, in comparison to other treatments. The objective is to generate meaningful insights that can be reported on the findings of the study.

---

## 1. Data Preparation

The first step is to **merge** two datasets: `mouse_metadata` and `study_results`. This will create a unified dataset containing all the relevant details for each mouse. It’s essential to check for **duplicate timepoints**, as any mouse with repeated data could skew the results. 

The process involves:
- Merging the datasets.
- Removing duplicates, ensuring unique entries for each mouse.
- Verifying that the dataset is clean and ready for analysis.

---

## 2. Summary Statistics

Next, we’ll calculate **summary statistics** for tumor volumes based on the treatment regimens. This includes the following measures for each treatment group:
- **Mean**
- **Median**
- **Variance**
- **Standard deviation**
- **Standard error of the mean (SEM)**

These statistics are essential to understand:
- **Central tendency** (e.g., mean and median), giving us an idea of the typical tumor response for each drug regimen.
- **Variability** (e.g., variance, standard deviation), highlighting the consistency of tumor volume responses. A high variance may indicate that the treatment isn’t consistently effective, warranting further investigation.

By comparing these statistics across regimens, we can assess which treatments provide more reliable results.

---

## 3. Visualization - Bar Charts & Pie Charts

To facilitate the communication of key insights, we’ll use visualizations:
- **Bar charts**: These will display the total number of observations (mice/timepoints) for each treatment regimen, highlighting the study's balance across different treatments.
- **Pie charts**: These will illustrate the gender distribution of the mice, ensuring there’s no significant bias towards male or female mice.

These visualizations help quickly convey the scope and fairness of the trial.

---

## 4. Quartile Calculation, Outliers, and Box Plots

To gain deeper insights into the treatment regimens, we'll focus on the **final tumor volumes** for each mouse:
- **Quartiles (Q1, Q3)** and **Interquartile Range (IQR)** will be calculated to detect **outliers**—mice whose responses are significantly different from the norm.
- **Box plots** will be created to visually represent the distribution of tumor volumes, clearly marking outliers.

Identifying outliers is crucial, as these data points could indicate either unusual responses to treatment or errors in the data collection process.

---

## 5. Line Plot and Scatter Plot

- **Line plot**: A line plot will track the tumor volume over time for a **Capomulin-treated mouse**. This will allow us to visually assess the tumor's progression and evaluate the drug’s effectiveness.
  
- **Scatter plot**: For all mice treated with Capomulin, we’ll create a scatter plot of **mouse weight** against **average tumor volume**. This will help explore whether there is any correlation between the weight of the mice and their tumor responses.

---

## 6. Correlation and Regression

The final step involves examining the relationship between **mouse weight** and **tumor volume** for **Capomulin-treated mice**:
- **Correlation coefficient**: We’ll calculate this to assess if there is a tendency for heavier mice to have larger tumors.
- **Linear regression**: We’ll model the relationship between mouse weight and tumor volume, potentially providing a predictive tool for tumor growth based on the physical characteristics of the mice.

---

## 7. Conclusion

This analysis offers a comprehensive, structured approach to evaluating the clinical trial data. The goal is to:
- Identify the most **effective treatment regimen**.
- Explore any potential **correlations**, such as between mouse weight and tumor growth.

The insights generated will provide stakeholders with data-driven conclusions to guide future research and decision-making regarding treatment effectiveness.
